<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>李进医生团队 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-26T20:32:09+08:00</updated>
  <subtitle>科普宣传，患者教育。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>抗癌路上 你我同在丨很幸运遇见你们，让我不惧癌魔</title>
    <updated>2020-11-26T16:37:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/SIV58nDN2DLaQczZlrdt6g</id>
    <link href="https://mp.weixin.qq.com/s/SIV58nDN2DLaQczZlrdt6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>张雪梅教授：肿瘤患者所关注的治疗相关疑问解答（上）</title>
    <updated>2020-11-25T20:44:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/5yjsTFc41vdAvnCMwOEOQA</id>
    <link href="https://mp.weixin.qq.com/s/5yjsTFc41vdAvnCMwOEOQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>令人绝望的癌痛，如何优雅面对？</title>
    <updated>2020-11-18T13:00:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/ndK9eLqlpxuv5zKZLdZq9Q</id>
    <link href="https://mp.weixin.qq.com/s/ndK9eLqlpxuv5zKZLdZq9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>说说MAPK那点事</title>
    <updated>2020-11-18T13:00:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/6aMeUzYwl_aJcdozW4XyPg</id>
    <link href="https://mp.weixin.qq.com/s/6aMeUzYwl_aJcdozW4XyPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>郭晔&amp;杨辉教授：靶向治疗破解治疗困局，安罗替尼高效安全优势显著</title>
    <updated>2020-11-17T11:39:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/PhwrPAxZ941G0g-n43u5_g</id>
    <link href="https://mp.weixin.qq.com/s/PhwrPAxZ941G0g-n43u5_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>周彩存教授：肺癌患者所关注的治疗相关疑问解答（下）</title>
    <updated>2020-11-10T16:20:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/YhgGOHJnfCqqfWF_qp22oQ</id>
    <link href="https://mp.weixin.qq.com/s/YhgGOHJnfCqqfWF_qp22oQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>松开肿瘤免疫环境的另一个刹车信号 ——抗TIGIT单克隆抗体</title>
    <updated>2020-11-09T19:13:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/1qUjHvb5Qri_yq7C2QjMcA</id>
    <link href="https://mp.weixin.qq.com/s/1qUjHvb5Qri_yq7C2QjMcA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>李进教授：PD-1、CLDN18.2靶点扎堆，从临床角度看抗癌新药机会何在？</title>
    <updated>2020-11-09T19:13:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/_NglRVM-a2-vkJ95kJuCxw</id>
    <link href="https://mp.weixin.qq.com/s/_NglRVM-a2-vkJ95kJuCxw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>践行初心使命，彰显责任担当 | 秦叔逵、马军、李进教授共话肿瘤继续教育新动向</title>
    <updated>2020-11-05T14:29:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/Q6dW9BG9n-_IwocXoWeWkA</id>
    <link href="https://mp.weixin.qq.com/s/Q6dW9BG9n-_IwocXoWeWkA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>周彩存教授：肺癌患者所关注的治疗相关疑问解答（上）</title>
    <updated>2020-11-04T15:05:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/5a1CAK2nRu3pKsXYlzKY6Q</id>
    <link href="https://mp.weixin.qq.com/s/5a1CAK2nRu3pKsXYlzKY6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亚洲肿瘤联盟主席李进：从医生角度看中国抗癌药的投资方向</title>
    <updated>2020-11-03T15:26:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/5j4dIFYNTwD3ML6s-_UsBA</id>
    <link href="https://mp.weixin.qq.com/s/5j4dIFYNTwD3ML6s-_UsBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗癌路上 你我同在｜临床试验——肿瘤患者涅槃重生的希望</title>
    <updated>2020-11-02T21:22:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/1ZOBRTs0SClsZNxtO0hC1g</id>
    <link href="https://mp.weixin.qq.com/s/1ZOBRTs0SClsZNxtO0hC1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>